Search results for "Coronavirus"
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
COVID-19 outcomes in health care workers and over the long term, vaccine evidence and uptake among the latest research
A study found that health care workers hospitalized with COVID-19 had shorter stays, while a survey showed high uncertainty about vaccination. Johnson & Johnson released efficacy data on a one-shot vaccine, and a study identified long-term decreases in function among COVID-19 survivors.
https://immattersacp.org/weekly/archives/2021/02/02/1.htm
2 Feb 2021
Q&A: Dealing with COVID-19 vaccine allocation, distribution
The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2021/02/02/2.htm
2 Feb 2021
ACP issues guidance on easing social distancing, recognizes role of internists during the pandemic
The College addressed what communities need to safely resume economic activities and in-person medical visits, and released a new video emphasizing the essential role of the internal medicine community.
https://immattersacp.org/weekly/archives/2020/05/12/2.htm
12 May 2020
Antibody therapy gets EUA, studies show pandemic's effects on emergency care
Sotrovimab received an emergency use authorization (EUA) for some high-risk outpatients with COVID-19, and multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic.
https://immattersacp.org/weekly/archives/2021/06/08/1.htm
8 Jun 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021
Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates
A monoclonal antibody treatment showed benefit in outpatients, data varied on duration of antibody response, cardiac effects appeared common while strokes were not, and mortality improved, among other recent findings on COVID-19.
https://immattersacp.org/weekly/archives/2020/11/03/1.htm
3 Nov 2020
New COVID-19-related guidance on CPR, chest imaging, hydroxychloroquine
Medical societies addressed appropriate resuscitation and chest imaging practices for patients with COVID-19, issued guidelines on treatment and management, and warned about arrhythmia risks with hydroxychloroquine and azithromycin.
https://immattersacp.org/weekly/archives/2020/04/14/1.htm
14 Apr 2020